Grant: Discovery Grants Program - Individual
Université Laval
$75,000.00
Medical physics and biomedical technology development for next generation dose measurement, optimization and computation tools
EF 2019-20
Résumé
Cancer is now the most important cause of premature death in industrialized country and around 50% of cancer patients will have one form of radiation therapy, alone and in combination with surgery and chemotherapy, as part of their treatments. As with any cytotoxic agents, radiation, which must be used safely, has the distinct advantages of being a local treatment modality for which the basic interaction processes with matter are well-known (relative to systemic chemotherapy agents) i.e. the physical dose and its spatial extension can be predicted with high precision. The search for novel approaches to cure or manage cancer is extremely active. Still, a recent review shows that cancers are mainly “cured” using surgery and radiation therapy. This is because surgery and radiation therapy are also benefiting from continuous technological and scientific advances. ******Our research program is rooted in this paradigm as the ongoing, long-term objective of the research program is to increase the accuracy of dose measurements, dose optimization and dose calculations for radiation-based precision medicine. This is achieved through a comprehensive research program combining elements of basic and applied research in medical physics and biomedical engineering. The proposed program hinges on radiation physics, optics, numerical optimization problems, image and signal processing and high-performance numerical computing. It is a well-established, wide-ranging and highly productive research program. The methodology used combines both experimental and numerical approaches to build tools and algorithms that are novel and clinically relevant to radiation medicine. ******The 5-year objectives for this renewal spreads along three main research tracks: ***1) Development of new plan optimization algorithms, ***2) Development of novel scintillation dosimeters, ***3) Monte Carlo method for radiation-matter simulations. ******Our close connection with clinical teams ensures that our program, and its 5-year objectives listed above, are strongly connected with real clinical need. More importantly, the application of the said technologies and algorithms that we are developing has the potential for improved precision of radiation medicine, and thus quality of life of patients, in Canada and worldwide. As a result, they are highly sought after by the various stakeholders (clinicians, researchers, ) as well as the biomedical technology industry partners, actual and future.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2019-05038
Name nom
Beaulieu, Luc
Department département
Physique, génie physique et optique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
75000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Installment
inst:1 - 5
Partie
1
Nb partie
5
Application title
Medical physics and biomedical technology development for next generation dose measurement, optimization and computation tools
Keyword
NSERC
Application summary
Cancer is now the most important cause of premature death in industrialized country and around 50% of cancer patients will have one form of radiation therapy, alone and in combination with surgery and chemotherapy, as part of their treatments. As with any cytotoxic agents, radiation, which must be used safely, has the distinct advantages of being a local treatment modality for which the basic interaction processes with matter are well-known (relative to systemic chemotherapy agents) i.e. the physical dose and its spatial extension can be predicted with high precision. The search for novel approaches to cure or manage cancer is extremely active. Still, a recent review shows that cancers are mainly “cured” using surgery and radiation therapy. This is because surgery and radiation therapy are also benefiting from continuous technological and scientific advances. ******Our research program is rooted in this paradigm as the ongoing, long-term objective of the research program is to increase the accuracy of dose measurements, dose optimization and dose calculations for radiation-based precision medicine. This is achieved through a comprehensive research program combining elements of basic and applied research in medical physics and biomedical engineering. The proposed program hinges on radiation physics, optics, numerical optimization problems, image and signal processing and high-performance numerical computing. It is a well-established, wide-ranging and highly productive research program. The methodology used combines both experimental and numerical approaches to build tools and algorithms that are novel and clinically relevant to radiation medicine. ******The 5-year objectives for this renewal spreads along three main research tracks: ***1) Development of new plan optimization algorithms, ***2) Development of novel scintillation dosimeters, ***3) Monte Carlo method for radiation-matter simulations. ******Our close connection with clinical teams ensures that our program, and its 5-year objectives listed above, are strongly connected with real clinical need. More importantly, the application of the said technologies and algorithms that we are developing has the potential for improved precision of radiation medicine, and thus quality of life of patients, in Canada and worldwide. As a result, they are highly sought after by the various stakeholders (clinicians, researchers, ) as well as the biomedical technology industry partners, actual and future.